New drugs show progress in the fight against cancer

June 1, 2014 6:10 AM

8 0

CHICAGO – New drugs are making a dent against some hard-to-treat cancers, but some results raise fresh questions about whether the benefit is worth the cost.

For the first time in a decade, an experimental drug has extended the lives of patients with advanced lung cancer who relapsed after standard chemotherapy. But the drug used in the study gave patients just six extra weeks of life on average, and costs $6,000 per infusion as currently sold to treat a...

Also read: How AT&T might skirt an FCC review of Time Warner deal

Read more

To category page